title: Cosmetics Europe multi-laboratory pre-validation of the EpiOcular™ reconstituted human tissue test method for the prediction of eye irritation.
abstract: Cosmetics Europe, The Personal Care Association (known as Colipa before 2012), conducted a program of technology transfer and within/between laboratory reproducibility of MatTek Corporation's EpiOcular™ Eye Irritation Test (EIT) as one of the two human reconstructed tissue test methods. This EIT EpiOcular™ used a single exposure period for each chemical and a prediction model based on a cut-off in relative survival [ ≤60%=irritant (I) (GHS categories 2 and 1); >60%=no classification (NC)]. Test substance single exposure time was 30 min with a 2-h post-exposure incubation for liquids and 90 min with an 18-h post-exposure incubation for solids. Tissue viability was determined by tetrazolium dye (MTT) reduction. Combinations of 20 coded chemicals were tested in 7 laboratories. Standardized laboratory documentation was used by all laboratories. Twenty liquids (11 NC/9 I) plus 5 solids (3 NC/2 I) were selected so that both exposure regimens could be assessed. Concurrent positive (methyl acetate) and negative (water) controls were tested in each trial. In all, 298 independent trials were performed and demonstrated 99.7% agreement in prediction (NC/I) across the laboratories. Coefficients of variation for the% survival for tissues from each treatment group across laboratories were generally low. This protocol has entered in 2010 the experimental phase of a formal ECVAM validation program.
authors.affiliation: Beiersdorf AG, Hamburg, Germany. Uwe.Pfannenbecker@Beiersdorf.com
authors.forename: U
authors.initials: U
authors.lastname: Pfannenbecker
authors.forename: S
authors.initials: S
authors.lastname: Bessou-Touya
authors.forename: C
authors.initials: C
authors.lastname: Faller
authors.forename: J
authors.initials: J
authors.lastname: Harbell
authors.forename: T
authors.initials: T
authors.lastname: Jacob
authors.forename: H
authors.initials: H
authors.lastname: Raabe
authors.forename: M
authors.initials: M
authors.lastname: Tailhardat
authors.forename: N
authors.initials: N
authors.lastname: Alépée
authors.forename: A
authors.initials: A
authors.lastname: De Smedt
authors.forename: B
authors.initials: B
authors.lastname: De Wever
authors.forename: P
authors.initials: P
authors.lastname: Jones
authors.forename: Y
authors.initials: Y
authors.lastname: Kaluzhny
authors.forename: B
authors.initials: B
authors.lastname: Le Varlet
authors.forename: P
authors.initials: P
authors.lastname: McNamee
authors.forename: M
authors.initials: M
authors.lastname: Marrec-Fairley
authors.forename: F
authors.initials: F
authors.lastname: Van Goethem
mesh_terms: D000826:Animal Testing Alternatives; D003299:Cooperative Behavior; D005060:Europe; D005123:Eye / Q000187:drug effects*; D006801:Humans; D066298:In Vitro Techniques; D007509:Irritants / Q000633:toxicity*; D007753:Laboratories; D008954:Models, Biological; D015203:Reproducibility of Results; D018581:Technology Transfer; D023382:Toxicity Tests, Acute / Q000379:methods*; D014481:United States
chemical_list: D007509:Irritants